Lantheus Holdings (LNTH) Depreciation and Depletion (2014 - 2016)
Lantheus Holdings' (LNTH) quarterly Depreciation and Depletion came in at -$5.4 million in Q4 2016, down 345.45% year-on-year from $2.2 million in Q1 2016, and down 357.14% on a QoQ basis from $2.1 million in Q3 2016.
Lantheus Holdings (LNTH) Depreciation and Depletion (2014 - 2016) Analysis & Trends
Lantheus Holdings (LNTH) has 3 years of Depreciation and Depletion data on file, last reported at -$5.4 million in Q4 2016.
- On a quarterly basis, Depreciation and Depletion fell 345.45% year-over-year to -$5.4 million in Q4 2016; TTM through Dec 2016 was $900000.0, a 92.37% decrease from a year earlier, with the FY2016 full-year figure at $800000.0, down 93.22% from the prior year.
- Depreciation and Depletion for Q4 2016 stood at -$5.4 million, down from $2.1 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for LNTH reached as high as $5.7 million in Q1 2015 and fell as low as -$5.4 million in Q4 2016.
- Historically, Depreciation and Depletion has averaged $1.9 million across 3 years, with a median of $2.1 million in 2014.
- On a YoY basis, Depreciation and Depletion climbed as much as 10.53% in 2016 and fell as far as 345.45% in 2016.
- Year by year, Depreciation and Depletion stood at $3.4 million in 2014, then tumbled by 35.29% to $2.2 million in 2015, then sank by 345.45% to -$5.4 million in 2016.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were -$5.4 million in Q4 2016, $2.1 million in Q3 2016, and $2.2 million in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -5.40 Mn |
| Dec 31, 2016 | -5.40 Mn |
| Sep 30, 2016 | 2.10 Mn |
| Sep 30, 2016 | 2.10 Mn |
| Jun 30, 2016 | 2.20 Mn |
| Jun 30, 2016 | 2.20 Mn |
| Mar 31, 2016 | 2.00 Mn |
| Mar 31, 2016 | 2.00 Mn |
| Dec 31, 2015 | 2.20 Mn |
| Dec 31, 2015 | 2.20 Mn |
| Sep 30, 2015 | 1.90 Mn |
| Sep 30, 2015 | 1.90 Mn |
| Jun 30, 2015 | 2.00 Mn |
| Jun 30, 2015 | 2.00 Mn |
| Mar 31, 2015 | 5.70 Mn |
| Mar 31, 2015 | 5.70 Mn |
| Dec 31, 2014 | 3.40 Mn |
| Dec 31, 2014 | 3.40 Mn |
| Sep 30, 2014 | 2.20 Mn |
| Sep 30, 2014 | 2.20 Mn |